Related Experiment Video
Updated: Jul 5, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candida endocarditis: role of new antifungal agents
J P Talarmin1, D Boutoille, P Tattevin
1Service des Maladies Infectieuses, Centre Hospitalier Universitaire, Hôpital Hôtel Dieu, Nantes, France.
Abstract:
Despite the relative high frequency of Candida bloodstream infection, Candida endocarditis is a rare entity. We report seven cases, which occurred during a period of 1 year in western France. Six cases were because of Candida albicans, and one pacemaker endocarditis was because of Candida parapsilosis. All patients were men and presented risk factors for candidaemia. Of the six patients with valvular involvement, five received caspofungin and two had surgical valve replacement. Three patients treated with caspofungin antifungal therapy without valve replacement were cured from endocarditis. Antifungal and surgical strategies are discussed, in particular, the possible role of new antifungal therapies and long-term suppression therapy without surgery. One patient died in the acute phase of endocarditis, three patients died of causes unrelated to infective endocarditis and three patients had a favourable outcome.
Insights
Candida endocarditis is rare, but this study reports seven cases. Caspofungin showed promise in treating fungal endocarditis, with some patients cured without surgery.
Area of Science:
- Infectious Diseases
- Cardiology
- Mycology
Background:
- Candida bloodstream infections are common, but Candida endocarditis remains a rare clinical diagnosis.
- This study focuses on a series of seven cases of Candida endocarditis observed over one year in western France.
Observation:
- Six cases involved Candida albicans, while one pacemaker endocarditis was attributed to Candida parapsilosis.
- All affected patients were male and had pre-existing risk factors for candidemia.
- Five patients with valvular involvement received caspofungin, and two underwent surgical valve replacement.
Findings:
- Three patients treated with caspofungin alone achieved a cure for their endocarditis.
- The study discusses the efficacy of antifungal and surgical interventions for this condition.
- Outcomes varied, with one acute death, three unrelated deaths, and three favorable outcomes.
Implications:
- New antifungal therapies, including caspofungin, may offer effective treatment options for Candida endocarditis.
- Long-term antifungal suppression therapy without surgery is a potential strategy to consider.
- Further research is warranted to optimize treatment protocols for this rare but serious infection.
Related Concept Videos
Antifungal Agents
Endocarditis III: Medical Management
Candidiasis
Cryptococcal Meningitis
Endocarditis I: Introduction
Endocarditis IV: Nursing Management

